Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

Mohammad Alhadj Ali(Cardiff University), Colin Dayan(University of Birmingham), Hina Shariff(King's College London), Vivienne B. Gibson(King's College London), YF Liu(Loma Linda University Medical Center), Natasha Thorogood(University Hospitals Bristol NHS Foundation Trust), Danijela Tatović(Cardiff University), Sefina Arif(Guy's Hospital), Kate Green(University Hospitals Bristol NHS Foundation Trust), Stephen D. Luzio(Swansea University), Nedyalko Petrov(King's College London), Zoe Boult(University Hospital of Wales), Susanne Heck(Guy's Hospital), F. Susan Wong(University Hospitals Birmingham NHS Foundation Trust), Nicola Leech(Newcastle upon Tyne Hospitals NHS Foundation Trust), Lorraine Yeo(King's College London), Martin Eichmann(King's College London), Frank Joseph(Countess of Chester Hospital NHS Foundation Trust), Lucas Baumard, Robert K. Hills(Cancer Research UK Clinical Trials Unit), Roman Baptista(Guy's Hospital), Irma Pujol‐Autonell(King's College London), Graham Bayly(University Hospitals Bristol NHS Foundation Trust), Rachel Stenson(Cardiff University), Gareth Dunseath(University Hospital Llandough), Timothy Tree(King's College London), Jennie H. M. Yang(Mayo Clinic), Mark Peakman(Sanofi (France)), Craig A. Beam(Western Michigan University), Susan T. Seal(Countess of Chester Hospital NHS Foundation Trust), HoYee Cheung(Countess of Chester Hospital NHS Foundation Trust), Robert Andrews(University of Exeter), Laura Adams(Guy's and St Thomas' NHS Foundation Trust), A Howell(Cardiff University), A.G. Clark(Cardiff University), Sunil Nair(Countess of Chester Hospital NHS Foundation Trust), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Alison O’Keefe(University Hospitals Bristol NHS Foundation Trust), Norkhairin Yusuf(King's College London)
Science Translational Medicine
August 9, 2017
Cited by 215


Related Papers